{ Spot Image }

ML files $4 billion fraud suit over cross-border M+A deal

September 2016

MoloLamken filed a suit in New York Supreme Court seeking more than $4 billion in compensatory and punitive damages on behalf of Israel-based global pharmaceutical manufacturer Teva.  The case emanates from Teva's acquisition of a major Mexican pharmaceutical company.  Read more here.